type 4 RTA

Type 4 RTA results from decreased aldosterone production (hypoaldosteronism) or aldosterone resistance at the level of the cortical collecting duct principal cells. Aldosterone normally stimulates Na+ reabsorption via ENaC channels and K+/H+ secretion via associated transporters. Deficiency or resistance leads to: (1) decreased Na+ reabsorption causing mild volume depletion, (2) decreased K+ secretion causing hyperkalemia, and (3) decreased H+ secretion (both directly and via reduced ammoniagenesis, since hyperkalemia impairs proximal tubule ammonia production) causing a mild non-anion gap metabolic acidosis. The hallmark is hyperkalemia that is disproportionate to the degree of renal insufficiency, along with impaired urinary acidification and low urine ammonium excretion.

Causes include: diabetic nephropathy (most common cause, due to hyporeninemic hypoaldosteronism from damage to the juxtaglomerular apparatus), primary adrenal insufficiency (Addison disease), medications that block the renin-angiotensin-aldosterone system (ACE inhibitors, ARBs, potassium-sparing diuretics like spironolactone/amiloride, NSAIDs, heparin, trimethoprim, pentamidine), and tubulointerstitial diseases (obstructive uropathy, lupus nephritis, sickle cell nephropathy).

Laboratory findings: hyperkalemia, non-anion gap metabolic acidosis, urine pH is typically <5.5 (unlike distal RTA where urine cannot be acidified), low serum aldosterone or evidence of aldosterone resistance, and low urinary ammonium excretion (best assessed via urine anion gap or urine osmolar gap).

Diagnosis is largely clinical, supported by finding hyperkalemia with mild renal insufficiency and confirming with plasma renin/aldosterone levels when needed.

Treatment focuses on correcting hyperkalemia and acidosis: dietary potassium restriction, loop diuretics to enhance urinary potassium excretion, sodium bicarbonate for acidosis, and fludrocortisone (mineralocorticoid replacement) in cases of true aldosterone deficiency. Discontinuing offending medications (ACE inhibitors, ARBs, NSAIDs) is essential when drug-induced.

Clinical pearl for boards: Type 4 RTA is the RTA associated with hyperkalemia (types 1 and 2 RTA cause hypokalemia). It's often tested in the context of a diabetic patient with mild renal insufficiency and unexplained hyperkalemia.